Phytecs focuses on products targeting the endocannabinoid system, which regulates nearly every process within our bodies from emotions to motor function.
May 2019 be a year of serenity, learning, mindfulness and growth in our personal lives, and continued investigation, discovery, fulfillment and success in our professional lives.
At this time of year marked by reflection, gratitude and sanctification, Phytecs extends its heartfelt appreciation to each and every collaborator and supporter from around the world who helped us take new and exciting steps on our strategic roadmap in 2018.
Phytecs' president Gary Hiller was honored to serve as the iCDP conference chair today, following Dr. Vincenzo Di Marzo’s gracious and insightful chairmanship on day 1.
The International Cannabinoid-Derived Pharmaceuticals (iCDP) summit concluded today with wonderful presentations covering patient perspectives, plant and synthetic innovations, and navigating FDA challenges. Looking forward to next year. #ICDPSummit2018.
Phytecs Pres Gary Hiller is looking forward to joining fellow leaders in cannabinoid-biotech R&D at next week’s International Cannabinoid Derived Pharmaceuticals Summit in Boston and to serving as the Chair for Day 2 of the conference. https://t.co/liTxkQ48rd #ICDPSummit2018
By focusing on properly characterized chemistries, the #cannabis industry can explore the use of structure/function claims to educate consumers and distinguish products.
At a recent @CBA_News seminar, attorney Sara Zborovski (with @NLawGlobal) urged the branding and marketing communities to collectively try to “get rid of the stigma and increase the credibility of this [cannabis] industry by not using silly words.”
She is 100% correct and we encourage the branding community to apply her advice and suggestions. We believe this should extend to other words such as indica, sativa and hybrid, since such terms have no actionable meaning to customers and should not impact a purchase decision.
In his presentation @CannXmed , Gary explored why positive anecdotal reports from patients on cannabis efficacy does not always align with negative published studies & explained how laboratory data could be used to inform and guide cannabis breeding work to increase efficacy.
In his presentation @CannXmed , Gary explored why positive anecdotal reports from patients on cannabis efficacy does not always align with negative published studies & explained how laboratory data could be used to inform and guide cannabis breeding work to increase efficacy.
Gary Hiller is joining leaders in the medical cannabis field @CannXmed. Look for his presentation on the importance of developing and using cannabis plants that are targeted for indications in order to be therapeutically effective rather than using generic “cannabis.” #cannx18
Phytecs President, Gary Hiller, will be attending and presenting at the #CannX2018 conference next week. For those attending, looking forward to seeing you there! https://t.co/2LDd7l6n9N
#CannX2018 is the ultimate meeting place for all physicians, researchers and experts in the medical cannabis ecosystem!
See who you will have the chance to meet in person at the event >> https://t.co/HiH8Akh80r
Starting Now! Join us for a #freewebinar with Dr. Tamás Biró, Dr. Heather Bradshaw and Dr. Yossi Tam, moderated by @SnowdenBishop to discuss the latest advancements in ECS research. Tune in at https://t.co/9JyIIpO9uZ
Starting Now! Join us for a free webinar with Snowden Bishop featuring some of the leading researchers in the world to discuss the latest advancements in ECS research. Tune in: https://t.co/9JyIIpO9uZ
In just a couple of hours @SnowdenBishop will be joining leading researchers in the ECS field to talk about the latest research. Participation is free. Tune in at https://t.co/9JyIIpO9uZ
The DEA’s rescheduling of Epidiolex, a natural botanical medication derived from cannabis, is an historic development that we hope brings relief to patients suffering from intractable diseases. https://t.co/Hs84RGk0ze
Join me Thurs. 8amPT/11amET for "Future of Cannabis Innovation" Webinar. I'm moderating the online panel discussion with renowned scientists on the endocannabinoid system presented by #Phytecs. Register to participate in Q&A #thecannabisreporter#ECS https://t.co/olBDMNjSPH
To get the most of the webinar, we recommend visiting the Phytecs website for background information on the endocannabinoid system. Make sure to come with questions! https://t.co/9NXkx8izNo
With @corona investing over $4 billion in the cannabis industry & @CocaCola reportedly eyeing the market, exploring cannabis research & understanding the ECS is critical in advancing its therapeutic use. We’re bringing together experts to talk innovation: https://t.co/DWRaHRlJlB